Investing

5 Biggest Pharmaceutical ETFs in 2025

The global pharmaceutical market reached a total value of US$1.38 trillion in 2024, according to Research and Markets, up significantly from the US$888 billion seen just over a decade earlier in 2010. Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma...
Read more

How to Invest in Rare Earth Metals

Investing in rare earth minerals can seem tricky, but there are a variety of rare earth stocks and exchange-traded funds (ETFs) available for metals investors. The rare earth sector may seem daunting, as many elements fall under the umbrella, and the 17 rare earth elements (REEs) are as diverse as they are challenging to pronounce....
Read more

Hazer and KBR Enter Global Deal to Accelerate Licensing and Commerciali

Hazer Group Ltd (‘Hazer’ or ‘the Company’) (ASX: HZR) is pleased to announce it has entered into a binding Alliance Agreement (the “Alliance”) with Kellogg Brown and Root LLC (NYSE: KBR, “KBR”) a global leader in technology and engineering solutions, for the commercial deployment and licensing of Hazer’s proprietary methane pyrolysis technology. Highlights Binding strategic...
Read more

Finlay Minerals Receives TSX Venture Exchange Approval for PIL Earn-In Agreement

finlay minerals ltd. (TSXV: FYL) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’) is pleased to announce the receipt of TSX Venture Exchange (the ‘ Exchange ‘) conditional acceptance for its previously announced earn-in agreement (the ‘ PIL Earn-In Agreement ‘) with Freeport-McMoRan Mineral Properties Canada Inc. (‘ Freeport ‘), a wholly owned subsidiary of Freeport-McMoRan Inc....
Read more